Cardiovascular Systems PE Ratio 2006-2019 | CSII

Current and historical p/e ratio for Cardiovascular Systems (CSII) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cardiovascular Systems PE ratio as of July 19, 2019 is 889.60.
Cardiovascular Systems PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-07-19 44.32 886.40
2019-03-31 38.66 $0.05 773.20
2018-12-31 28.49 $0.04 712.25
2018-09-30 39.14 $0.02 1957.00
2018-06-30 32.34 $0.05 646.80
2018-03-31 21.93 $-0.04 0.00
2017-12-31 23.69 $-0.10 0.00
2017-09-30 28.15 $-0.06 0.00
2017-06-30 32.23 $-0.06 0.00
2017-03-31 28.28 $-0.23 0.00
2016-12-31 24.21 $-0.87 0.00
2016-09-30 23.74 $-1.37 0.00
2016-06-30 18.38 $-1.72 0.00
2016-03-31 10.37 $-1.84 0.00
2015-12-31 15.12 $-1.49 0.00
2015-09-30 15.84 $-1.19 0.00
2015-06-30 26.45 $-1.04 0.00
2015-03-31 39.04 $-1.08 0.00
2014-12-31 30.08 $-1.06 0.00
2014-09-30 23.63 $-1.21 0.00
2014-06-30 31.16 $-1.24 0.00
2014-03-31 31.79 $-1.21 0.00
2013-12-31 34.29 $-1.18 0.00
2013-09-30 20.05 $-1.14 0.00
2013-06-30 21.20 $-1.11 0.00
2013-03-31 20.48 $-1.07 0.00
2012-12-31 12.55 $-1.01 0.00
2012-09-30 11.56 $-0.96 0.00
2012-06-30 9.79 $-0.92 0.00
2012-03-31 9.25 $-0.83 0.00
2011-12-31 9.85 $-0.75 0.00
2011-09-30 11.39 $-0.65 0.00
2011-06-30 14.56 $-0.71 0.00
2011-03-31 10.83 $-0.85 0.00
2010-12-31 11.66 $-1.14 0.00
2010-09-30 5.24 $-1.47 0.00
2010-06-30 4.48 $-1.62 0.00
2010-03-31 5.31 $-1.73 0.00
2009-12-31 4.59 $0.53 8.66
2009-09-30 7.27 $0.99 7.34
2009-06-30 7.71 $-2.28 0.00
2009-03-31 7.09 $-8.78 0.00
2008-12-31 9.30 $-13.90 0.00
2008-09-30 12.10 $-13.90 0.00
2008-06-30 13.50 $-14.80 0.00
2008-03-31 14.00 $8.60 1.63
2007-12-31 31.00 $8.70 3.56
2007-09-30 64.60 $8.70 7.43
2007-06-30 58.00 $11.10 5.23
2007-03-31 55.60 $-8.30 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.549B $0.217B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.825B 29.16
Medtronic (MDT) Ireland $135.913B 19.41
Stryker (SYK) United States $78.520B 28.02
Boston Scientific (BSX) United States $59.297B 28.43
Baxter (BAX) United States $42.385B 26.71
EssilorLuxottica Societe Anonyme (ESLOY) France $29.267B 0.00
Coloplast (CLPBY) Denmark $25.937B 41.41
Zimmer Biomet Holdings (ZBH) United States $25.411B 16.33
Lonza Group Ag (LZAGY) Switzerland $25.385B 0.00
Terumo (TRUMY) Japan $21.889B 25.17
Smith & Nephew SNATS (SNN) United Kingdom $19.108B 0.00
ResMed (RMD) United States $17.890B 34.18
Canopy Growth (CGC) Canada $12.379B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.239B 48.98
Insulet (PODD) United States $7.299B 531.83
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Hill-Rom Holdings (HRC) United States $7.083B 21.47
Aurora Cannabis (ACB) Canada $7.048B 69.50
Perrigo (PRGO) Ireland $6.991B 11.82
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.299B 51.41
ICU Medical (ICUI) United States $5.103B 30.45
GW Pharmaceuticals (GWPH) United Kingdom $5.007B 0.00
Neogen (NEOG) United States $3.388B 55.09
NuVasive (NUVA) United States $3.018B 24.64
Agios Pharmaceuticals (AGIO) United States $2.894B 0.00
Hutchison China MediTech (HCM) China $2.829B 0.00
National Vision Holdings (EYE) United States $2.507B 53.42
Quidel (QDEL) United States $2.307B 23.94
Aphria (APHA) $1.619B 0.00
Phibro Animal Health (PAHC) United States $1.229B 18.42
AtriCure (ATRC) United States $1.216B 0.00
VAREX IMAGING (VREX) United States $1.171B 24.86
NanoString Technologies (NSTG) United States $1.107B 0.00
Lantheus Holdings (LNTH) United States $1.086B 28.83
PetIQ (PETQ) United States $1.002B 24.33
Quanterix (QTRX) United States $0.820B 0.00
Cerus (CERS) United States $0.773B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.761B 21.35
Omeros (OMER) United States $0.760B 0.00
MacroGenics (MGNX) United States $0.739B 0.00
TG Therapeutics (TGTX) United States $0.701B 0.00
LeMaitre Vascular (LMAT) United States $0.608B 29.43
Surmodics (SRDX) United States $0.538B 78.24
OraSure Technologies (OSUR) United States $0.525B 24.17
Meridian Bioscience (VIVO) United States $0.492B 15.03
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.465B 0.00
Vapotherm (VAPO) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.324B 22.45
BioLife Solutions (BLFS) United States $0.319B 99.82
Cytosorbents (CTSO) United States $0.246B 0.00
Zynex (ZYXI) United States $0.239B 24.60
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.186B 0.00
United Health Products (UEEC) United States $0.171B 0.00
Rockwell Medical (RMTI) United States $0.167B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.139B 7.32
Female Health (VERU) United States $0.138B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.079B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.056B 19.25
MRI INTERVENTNS (MRIC) United States $0.052B 0.00